Suven Pharmaceuticals Limited (SUVENPHAR.BO)
INR 1081.15
(2.68%)
INR 1081.15
(2.68%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.4 Billion INR | -72.16% |
| 2022 | 2.19 Billion INR | 14.39% |
| 2021 | 1.91 Billion INR | 29.34% |
| 2020 | 1.48 Billion INR | 20.79% |
| 2019 | 1.22 Billion INR | 135.81% |
| 2018 | 520.87 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 144.6 Million INR | 128.8% |
| 2023 Q2 | 581.02 Million INR | -2.48% |
| 2023 Q4 | 199.38 Million INR | -67.99% |
| 2023 FY | 611.09 Million INR | -72.16% |
| 2023 Q3 | 622.85 Million INR | 7.2% |
| 2023 Q1 | 595.78 Million INR | 53.81% |
| 2022 Q3 | 623.14 Million INR | 6.64% |
| 2022 Q1 | 600.17 Million INR | 28.09% |
| 2022 FY | 2.19 Billion INR | 14.39% |
| 2022 Q4 | 387.36 Million INR | -37.84% |
| 2022 Q2 | 584.35 Million INR | -2.64% |
| 2021 Q1 | 425.86 Million INR | 85.97% |
| 2021 FY | 1.91 Billion INR | 29.34% |
| 2021 Q4 | 468.57 Million INR | -6.98% |
| 2021 Q3 | 503.72 Million INR | -3.27% |
| 2021 Q2 | 520.75 Million INR | 22.28% |
| 2020 Q4 | 228.99 Million INR | -48.7% |
| 2020 Q3 | 446.4 Million INR | 2.18% |
| 2020 Q2 | 436.89 Million INR | 11.84% |
| 2020 FY | 1.48 Billion INR | 20.79% |
| 2020 Q1 | 390.64 Million INR | 112.45% |
| 2019 Q2 | 354.59 Million INR | 3.87% |
| 2019 FY | 1.22 Billion INR | 135.81% |
| 2019 Q3 | 336.09 Million INR | -5.22% |
| 2019 Q4 | 183.88 Million INR | -45.29% |
| 2019 Q1 | 341.38 Million INR | 44.81% |
| 2018 Q4 | 235.74 Million INR | -17.32% |
| 2018 Q3 | 285.13 Million INR | 0.0% |
| 2018 FY | 520.87 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 91.161% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 96.425% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 87.949% |
| Granules India Limited | 7.18 Billion INR | 80.469% |
| Indoco Remedies Limited | 4.74 Billion INR | 70.46% |
| Achyut Healthcare Limited | 1.6 Million INR | -87083.903% |
| Ajanta Pharma Limited | 30.46 Billion INR | 95.395% |
| Alkem Laboratories Limited | 32.83 Billion INR | 95.728% |
| Alpa Laboratories Limited | 156.14 Million INR | -798.377% |
| Brooks Laboratories Limited | 51.18 Million INR | -2640.893% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | 46.055% |
| Bajaj HealthCare Limited | 985.34 Million INR | -42.365% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | 1.158% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.537% |
| Eris Lifesciences Limited | 4.94 Billion INR | 71.62% |
| FDC Limited | 5.34 Billion INR | 73.772% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 97.924% |
| Gufic Biosciences Limited | 1.07 Billion INR | -30.164% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | 33.961% |
| Ipca Laboratories Limited | 13.91 Billion INR | 89.919% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -81.377% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2939.234% |
| Lasa Supergenerics Limited | 291.17 Million INR | -381.77% |
| Laurus Labs Limited | 3.01 Billion INR | 53.408% |
| Lupin Limited | 95.67 Billion INR | 98.534% |
| Mankind Pharma Limited | 23.15 Billion INR | 93.941% |
| Medicamen Biotech Limited | 335.16 Million INR | -318.534% |
| Medico Remedies Limited | 161.84 Million INR | -766.754% |
| Megasoft Limited | 49.52 Million INR | -2732.315% |
| NATCO Pharma Limited | 10.05 Billion INR | 86.053% |
| Piramal Pharma Limited | 19.91 Billion INR | 92.956% |
| RPG Life Sciences Limited | 1.63 Billion INR | 14.229% |
| Sigachi Industries Limited | 579.88 Million INR | -141.907% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.09% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -48.853% |
| Unichem Laboratories Limited | 6.72 Billion INR | 79.143% |
| Wanbury Limited | 1.16 Billion INR | -20.834% |
| Windlas Biotech Limited | 1 Billion INR | -39.372% |
| ZIM Laboratories Limited | 1.01 Billion INR | -38.471% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 96.751% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 54.408% |
| Divi's Laboratories Limited | 14.17 Billion INR | 90.1% |
| Hester Biosciences Limited | 908.84 Million INR | -54.349% |
| Procter & Gamble Health Limited | 2.99 Billion INR | 53.169% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -27.644% |
| Bal Pharma Limited | 389.89 Million INR | -259.791% |
| Strides Pharma Science Limited | 9.16 Billion INR | 84.69% |
| Venus Remedies Limited | 1.91 Billion INR | 26.796% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | 54.372% |
| Nectar Lifesciences Limited | 625.55 Million INR | -124.249% |
| Shilpa Medicare Limited | 2.18 Billion INR | 35.669% |
| Aarti Drugs Limited | 1.16 Billion INR | -20.155% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -27.666% |
| Suven Life Sciences Limited | 109.75 Million INR | -1178.168% |
| Ind-Swift Limited | 946.56 Million INR | -48.198% |
| Valiant Laboratories Limited | 36.28 Million INR | -3765.604% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 83.334% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | 69.369% |
| Themis Medicare Limited | 782.85 Million INR | -79.189% |
| Hikal Limited | 2.48 Billion INR | 43.58% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 93.452% |
| Sequent Scientific Limited | 2.9 Billion INR | 51.658% |
| Novartis India Limited | 470.1 Million INR | -198.402% |
| Wockhardt Limited | 6.4 Billion INR | 78.081% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 90.295% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -8554.01% |
| Neuland Laboratories Limited | 2.92 Billion INR | 52.119% |
| Morepen Laboratories Limited | 1.98 Billion INR | 29.418% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -240.13% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -107.468% |